Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology
Disease Category: Aplastic Anemia
Trial Information
Examination of PNH, by Level Of CD59 on REd and white blood cells, in bone marrow failure syndromes (EXPLORE)
** This study is an observational prevelance study.
The primary objectives are to determine the occurrence of Paroxysmal Nocturnal Hemoglobinuria (PNH) cells in people with Aplastic Anemia (AA), Myelodysplastic Syndromes (MDS), and other bone marrow failure syndromes.
The secondary objectives are to understand the relationship between different bone marrow failure syndromes and the different characteristics of PNH.
Patient Inclusion Criteria:
- Is at least 18 years of age.
- Is willing to comply with the protocol.
- Is willing and able to give written informed consent.
- Has AA, MDS, or other bone marrow failure syndromes.
Patient Exclusion Criteria:
See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.
West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South
PO Box 9260
Morgantown, WV 26506
Phone: 304-293-7374
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
